Merck KGaA, Cancer Research UK, ICR Launch Three Drug Discovery Projects

Cancer Research UK and the Institute of Cancer Research, London (ICR), said they will partner with Merck KGaA on three research projects focused on cancer drug discovery, expanding on several earlier collaborations focused on discovering single treatments and validating targets for new therapies.Under the latest collaboration and licensing deal—whose value was not disclosed—Merck KGaA would join Cancer Research UK and ICR on projects ranging from target hit discovery to nomination of